Holen Sie sich die Stockscreener-App
13.38
2.92%
0.38
Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
5.38%
115.79
|
122.37 | 97.11 | 105.66 | 71.96 |
| Operating Income/Loss |
5.38%
-115.79
|
-122.37 | -97.11 | -105.66 | -71.96 |
| Income/Loss From Continuing Operations Before Tax |
3.90%
-110.86
|
-115.36 | -89.54 | -97.12 | -65.10 |
| Income/Loss From Continuing Operations After Tax |
3.90%
-110.86
|
-115.36 | -89.54 | -97.12 | -65.10 |
|
Net Income/Loss
|
3.90%
-110.86
|
-115.36 | -89.54 | -97.12 | -65.10 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
7.62%
-0.97
|
-1.05 | -0.88 | -0.96 | -0.70 |
| Diluted Earnings Per Share |
7.62%
-0.97
|
-1.05 | -0.88 | -0.96 | -0.70 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):